Probiotic Bifidobacterium species: potential beneficial effects in diarrheal disorders. Focus on “Probiotic Bifidobacterium species stimulate human SLC26A3 gene function and expression in intestinal epithelial cells”

Probiotic Bifidobacterium species stimulate human SLC26A3 gene function and expression in intestinal epithelial cells

(2014) Anoop Kumar et al.   AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

Probiotics tailored to the infant: a window of opportunity

(2014) Christophe Chassard et al.   CURRENT OPINION IN BIOTECHNOLOGY

Lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in older inpatients (PLACIDE): a randomised, double-blind, placebo-controlled, multicentre trial

(2013) Stephen J Allen et al.   LANCET

New therapeutic targets in ulcerative colitis: The importance of ion transporters in the human colon

(2010) Klaudia Farkas et al.   INFLAMMATORY BOWEL DISEASES

Randomized controlled trial of live lactobacillus acidophilus plus bifidobacterium bifidum in prophylaxis of diarrhea during radiotherapy in cervical cancer patients

(2010) Imjai Chitapanarux et al.   Radiation Oncology

Decreased Expression of Colonic Slc26a3 and Carbonic Anhydrase IV as a Cause of Fatal Infectious Diarrhea in Mice

(2009) D. Borenshtein et al.   INFECTION AND IMMUNITY

Functional coupling of the downregulated in adenoma Cl−/base exchanger DRA and the apical Na+/H+ exchangers NHE2 and NHE3

(2008) Mark W. Musch et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY